Skip to main content
. 2020 Mar 26;17(1):1819–1824. doi: 10.1016/j.sapharm.2020.03.012

Fig. 1.

Fig. 1

An overview of the recommended content of community pharmaceutical care services during the COVID-19 outbreak.